Facilitating Access to Specialty Treatment

May 20, 2026 updated by: Children's Hospital of Philadelphia

Utilizing Mobile Health to Expedite Access to Specialty Care for Youth Presenting to the Emergency Department With Concussion at Highest Risk of Developing Persisting Symptoms

The goal of this hybrid implementation-effectiveness study is to evaluate the effectiveness (hastened recovery times) and feasibility (fidelity in connecting to concussion specialty care) of a novel mobile health intervention, designed to reduce disparities in access to specialty care through the use of remote patient monitoring (RPM) to facilitate care hand-off from the emergency department (ED) to concussion specialty care. Participants will report their symptoms and activity once daily through RPM chat technology that is linked to their electronic health record and prompts referral to specialty care.

Study Overview

Detailed Description

Patients will be evaluated using the 5P rule. Those scoring 4 or higher (moderate to high risk for persistent post-concussion symptoms) and meeting all other eligibility criteria will be enrolled. A remote patient monitoring chat platform will prompt subjects to report their current symptoms and activity once daily throughout the acute study period (up to 28 days following injury). A nurse navigator will have access to the symptom data within the electronic health record and will facilitate scheduling of in-person or telehealth visits with a concussion specialist as needed throughout the recovery period. Semi-structured interviews will be conducted with patient/parent dyads as well as providers to assess their perception of the appropriateness and acceptability of the intervention as well as facilitators and barriers to the mHealth-facilitated referral model. The intervention is designed to reduce barriers to specialist access and improve care continuity and health system navigation.

Study Type

Interventional

Enrollment (Estimated)

210

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Recruiting
        • Children's Hospital of Philadelphia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 17 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria for concussed subjects:

  • Males and females age 13 - 18
  • Present to the Children's Hospital of Philadelphia (CHOP) Emergency Department (ED) within 72 hours of head injury
  • Meet criteria for concussion as defined by the most recent International Consensus Statement on Concussion
  • Own a smartphone
  • Meet criteria for moderate-to-high risk for Persistent Post-Concussion Symptoms according to 5P rule (score >3/12)

Exclusion Criteria for concussed subjects:

  • Glasgow Coma Scale score <13
  • Lower extremity trauma
  • A prior concussion within 1 month
  • Non-English speaking
  • Admission to the hospital at the initial head injury visit
  • Previously enrolled in the study
  • Inability to complete study procedures.

Inclusion Criteria for parents:

  • Child meets the study eligibility criteria

Exclusion Criteria for parents:

  • Non-English speaking

Inclusion Criteria for providers:

  • ED or specialty provider caring for at least one patient via the mobile Health (mHealth)-facilitated care handoff strategy

Exclusion Criteria for providers:

  • Non-English speaking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Concussed youth at risk for prolonged symptoms
Participants will be prompted to report current symptoms and activity once a day via remote patient monitoring chat technology for up to 28 days following injury. Patients with either escalating or plateauing symptoms will be flagged, with an electronic alert sent via the electronic health record to a nurse navigator. The nurse navigator will have access to the symptom data and facilitate scheduling an in person or telehealth specialist visit as indicated. Symptoms will continue to be monitored through the 28-day acute study period with additional clinical visits occurring according to clinical need.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Persisting Post-Concussion Symptoms (PPCS, Primary Effectiveness)
Time Frame: 28 days from injury
Persistence of at least 3 concussion-like symptoms above the pre-injury state beyond 28 days from injury, defined as a positive difference between patient-reported symptoms and the perceived pre-injury symptom rating
28 days from injury
Percent of participants meeting referral criteria who interact with a specialty care provider (Fidelity, Primary Implementation)
Time Frame: 28 days from injury
Among those participants who flag to see a specialist, at least 1 interaction with a specialty provider either in person or via telehealth during the acute study period
28 days from injury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modeling of PPCS (Secondary Effectiveness)
Time Frame: 28 days from injury
Multivariate logistic regression evaluating the effect on the incidence of PPCS of socio-demographic and neighborhood-level economic variables, including race, ethnicity, sex, insurance, mechanism of injury, and child opportunity index, as well as known factors associated with PPCS, including age, concussion history, and co-morbid conditions
28 days from injury
Days until return to symptoms baseline (Secondary Effectiveness)
Time Frame: Up to 90 days from injury
Number of days from injury whereby patient-reported symptoms meets pre-injury baseline levels
Up to 90 days from injury
Days until clearance (Secondary Effectiveness)
Time Frame: Up to 90 days from injury
Number of days from injury until patient is fully cleared for full activity by a medical provider
Up to 90 days from injury
Days until return to school (Secondary Effectiveness)
Time Frame: Up to 90 days from injury
Number of days from injury until patient is able to return to full time school without accommodations
Up to 90 days from injury
Modeling of fidelity (Secondary Implementation)
Time Frame: 28 days from injury
Multivariate logistic regression evaluating the effect on fidelity of socio-demographic and neighborhood-level economic variables, including race, ethnicity, sex, insurance, mechanism of injury, and child opportunity index
28 days from injury
Patient-defined quantitative appropriateness (Secondary Implementation)
Time Frame: Within 1 year of completing study procedures
Mean System Usability Score out of 100 with >=70 defined as acceptable appropriateness
Within 1 year of completing study procedures
Patient-defined qualitative appropriateness (Secondary Implementation)
Time Frame: Within 1 year of completing study procedures
Themes from semi-structured interviews with patients related to intervention appropriateness will be identified
Within 1 year of completing study procedures
Provider-defined qualitative acceptability (Secondary Implementation)
Time Frame: Within 1 year of completing study procedures
Themes from semi-structured interviews with providers related to intervention acceptability will be identified
Within 1 year of completing study procedures

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Persistent Post-Concussion Symptoms (PPCS)
Time Frame: 28 days from injury
Persistence of at least 3 concussion-like symptoms above the pre-injury state beyond 28 days from injury, defined as a positive difference between patient-reported symptoms and the perceived pre-injury symptom rating
28 days from injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Daniel J Corwin, MD, MSCE, Children's Hospital of Philadelphia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 11, 2024

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

February 14, 2023

First Submitted That Met QC Criteria

February 14, 2023

First Posted (Actual)

February 23, 2023

Study Record Updates

Last Update Posted (Actual)

May 22, 2026

Last Update Submitted That Met QC Criteria

May 20, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Traumatic Brain Injury

Clinical Trials on RPM-assisted specialist access

Subscribe